Equities

Abliva AB

Abliva AB

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)0.187
  • Today's Change0.003 / 1.74%
  • Shares traded1.08m
  • 1 Year change-22.41%
  • Beta1.2536
Data delayed at least 15 minutes, as of Sep 19 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Abliva AB is a Sweden-based company involved in pharmaceutical industry. The Company focuses on the development of novel treatments for primary mitochondrial diseases.

  • Revenue in SEK (TTM)137.00k
  • Net income in SEK-102.13m
  • Incorporated2000
  • Employees6.00
  • Location
    Abliva ABMedicon Village, Scheeletorget 1LUND 223 81SwedenSWE
  • Phone+46 462756220
  • Fax+46 468888348
  • Websitehttps://abliva.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Biovica International AB7.25m-115.45m221.95m27.00--2.48--30.61-1.73-1.730.10551.060.058417.304.76226,593.80-92.98-51.94-110.37-58.18-394.72-576.01-1,592.15-2,217.413.47--0.0721--115.4919.39-12.97---54.31--
Thor Medical ASA0.00-17.89m228.66m1.00--0.9123-----0.08730.0210.001.110.00----0.00-9.82-79.17-10.54-113.94------------0.0035--------------
Kancera AB0.00-53.07m235.10m5.00--2.83-----0.5955-0.59550.000.68490.00----0.00-56.73-54.82-66.40-66.21--96.28---7,249.06----0.00-------23.64------
Xbrane Biopharma AB191.89m-340.89m261.24m71.00--0.8578--1.36-1.01-1.260.34030.19910.2090.702824.132,063,301.00-37.14-40.98-66.96-67.2443.32---177.65-364.401.07-20.510.357--314.3363.42-91.10--60.02--
Ascelia Pharma AB0.00-61.78m261.82m13.00--2.85-----1.26-1.260.000.95540.00----0.00-52.75---65.92-------------40.420.4167------16.72------
Intervacc AB9.78m-102.66m287.80m15.00--1.42--29.43-1.36-1.360.12912.680.03553.191.62651,933.30-37.23-17.62-40.38-18.77-551.10-243.59-1,049.76-626.902.90--0.0006---17.23-25.79-60.31---38.72--
Abliva AB137.00k-102.13m296.26m6.00--2.88--2,162.51-0.0928-0.09280.00010.06380.0013--0.0062---93.81-74.59-103.87-86.98-35,826.28---74,542.34-65,958.89----0.00--341.9493.89-12.02---19.74--
Annexin Pharmaceuticals AB (publ)0.00-52.36m304.86m4.00--8.46-----0.1873-0.18730.000.06760.00----0.00-162.59-125.42-220.41-151.33------------0.00-------8.17------
Xintela AB381.00k-40.83m307.13m--------806.12-0.0817-0.08170.0008-0.03190.0306--0.0493---327.65-181.06---391.61100.00---10,717.06-235,894.00---203.91-------45.5418.32---61.47--
Herantis Pharma Oyj0.00-6.95m322.71m10.00--13.9313.70---0.0146-0.01460.000.10120.00----0.00-13.93-80.46-27.32-104.37------------0.0145------103.00------
Lifecare ASA15.52m-49.93m329.43m32.00--2.77--21.23-0.3152-0.31520.09990.6320.1564----502,995.00-50.29-40.00-56.16-45.26-----321.48-175.53----0.0918---40.8830.29-101.74------
Alzinova AB300.00k-18.12m331.70m5.00--1.97--1,105.65-0.332-0.3320.00551.890.0025--0.475260,000.00-15.15-10.77-15.91-11.27-2,621.00---6,039.67-18,447.90---392.890.0076-------25.92--15.81--
Bergenbio ASA502.23k-149.81m338.17m15.00--2.00--673.33-5.37-5.370.0184.480.0023--0.041120,840.00-67.73-66.15-85.55-78.74-----29,828.21-11,419.44----0.00---9.00-31.4336.98------
Curasight A/S-43.27m-48.34m340.56m4.00--17.64-----1.51-1.51-1.350.6008-0.7563-----7,107,500.00-84.49-24.61-111.31-26.01-----------32.260.4439---123.97---42.62------
Lytix Biopharma AS-96.40bn-96.40bn367.28m10.00--6.43----------1.19-----------56.91---65.83-------771.78----0.0482---63.8263.94-56.77------
SynAct Pharma AB0.00-165.96m368.36m5.00--1.97-----4.75-4.750.004.530.00----0.00-61.52-125.17-67.60-151.70-----------231.850.0076-------117.54------
Data as of Sep 19 2024. Currency figures normalised to Abliva AB's reporting currency: Swedish Krona SEK

Institutional shareholders

1.45%Per cent of shares held by top holders
HolderShares% Held
Handelsbanken Fonder ABas of 31 Aug 20247.44m0.46%
Skandia Investment Management ABas of 31 Jul 20246.67m0.41%
FCG Fonder ABas of 30 Aug 20244.72m0.29%
SEB Investment Management ABas of 30 Aug 20243.45m0.21%
Storebrand Asset Management ASas of 30 Jun 2024811.31k0.05%
Skandia Fonder ABas of 31 Jul 2024245.36k0.02%
More ▼
Data from 30 Jun 2024 - 30 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.